Latest Caspase Stories
The molecular machines that defend our body against infection donâ€™t huff and puff, but some of them apparently operate on the same principle as a steam engine.
MALVERN, Pa., May 24, 2011 /PRNewswire/ -- TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced that is has closed a $6 million investment with new investor Nextech Invest Ltd., a Zurich, Switzerland, based oncology focused venture capital fund.
Most degenerative diseases begin with a gradual loss of specific cell types that progresses, eventually leading to symptoms.
Cell biologists pondering the death of neurons â€” brain cells â€” said today that by eliminating one ingredient from the cellular machinery, they prolonged the life of neurons stressed by a pesticide chemical.
Neurodegenerative diseases like Alzheimer's and Parkinson's are partly attributable to brain inflammation.
An enzyme viewed as an executioner, because it can push cells to commit suicide, may actually short circuit a second form of cell death.
Work led by St. Jude Children's Research Hospital scientists identified how cells flip a switch between cell survival and cell death that involves a protein called FLIP.
Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually.
Cardiologists at the University of Connecticut Health Center have identified a protein fragment that when detected in the blood can be a predictor of heart attack.
MALVERN, Pa., Jan. 5, 2011 /PRNewswire/ -- TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced that is has closed the $23 million second tranche of a Series C financing completed in October 2010.
- To give a box on the ear to.